Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Sep;44(3):135-41.
doi: 10.2478/v10019-010-0018-8. Epub 2010 Sep 9.

Post-treatment surveillance in colorectal cancer

Affiliations

Post-treatment surveillance in colorectal cancer

Vaneja Velenik. Radiol Oncol. 2010 Sep.

Abstract

Background: Though the post treatment surveillance of patients with colorectal cancer (CRC) treated with curative intent is common practice, its value is controversial. In the absence of conclusive clinical data, various modalities for the routine follow-up of patients with CRC have been proposed. In practice, the guidelines across countries and regions differ and are influenced by different health care policies, resource availability and doubts about effectiveness of follow-up.

Conclusions: The results of metaanalyses of available clinical trials demonstrated a survival benefit of intensified monitoring, but the questions regarding the optimal frequency of visits and the examinations to be performed remain unanswered. Furthermore, intensive monitoring of CRC survivors may be difficult to be administrated, causes discomfort and morbidity to the patient and can have serious cost-implications to the healthcare system. However, as it seems from available data, a comprehensive surveillance program does not affect the quality of patients' life. Ongoing large prospective multi-institutional randomised trials might elucidate some of the crucial questions and existing dilemmas to establish adequate surveillance strategy for CRC patients.

Keywords: colorectal cancer; surveillance.

PubMed Disclaimer

References

    1. Cancer incidence in Slovenia 2006. Report no. 48. Ljubljana: Institute of Oncology Ljubljana, Cancer Registry of Republic of Slovenia; 2009.
    1. Primic Žakelj M, Zadnik V, Žagar T, Zakotnik B. Survival of cancer patients, diagnosed in 1991–2005 in Slovenia. Ljubljana: Institute of Oncology Ljubljana, Cancer Registry of Republic of Slovenia; 2009.
    1. Goldberg RM, Fleming TR, Tangen CM, Moertel CG, Macdonald JS, Haller DG, et al. Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Ann Intern Med. 1998;129:27–35. - PubMed
    1. Velenik V. Locally recurrent rectal cancer: treatment options. Radiol Oncol. 2009;43:144–51.
    1. Cali RL, Pitsch RM, Thorson AG, Watson P, Tapia P, Blatchford GJ, et al. Cumulative incidence of metachronous colorectal cancer. Dis Colon Rectum. 1993;36:388–93. - PubMed

LinkOut - more resources